PAPER Guldbrandsen A, Farag YM, Lereim RR, Berven FS, Barsnes H
SEARCH RESULTS
3963 RESULTS
PAPER Riancho J, Santurtun A, Sánchez-Juan P
Characterization of Alzheimer's Disease Micro-RNA Profile in Exosome-Enriched CSF Samples.
Methods Mol Biol. 2019;2044:343-352. PubMed: 31432424PAPER Tepmongkol S, Hemrungrojn S, Dupont P, Tunvirachaisakul C, Aniwattanapong D, Likitjareon Y, Supasitthumrong T, Tawankanjanachot I, Siritranon N, Chuchuen P, Natsawang B, Tangwongchai S
Early prediction of donepezil cognitive response in Alzheimer's disease by brain perfusion single photon emission tomography.
Brain Imaging Behav. 2019 Dec;13(6):1665-1673. PubMed: 31432319PAPER Hughes LE, Henson RN, Pereda E, Bruña R, López-Sanz D, Quinn AJ, Woolrich MW, Nobre AC, Rowe JB, Maestú F, BioFIND Working Group
Biomagnetic biomarkers for dementia: A pilot multicentre study with a recommended methodological framework for magnetoencephalography.
Alzheimers Dement (Amst). 2019 Dec;11:450-462. Epub 2019 Jun 14 PubMed: 31431918PAPER Hijazi S, Heistek TS, Scheltens P, Neumann U, Shimshek DR, Mansvelder HD, Smit AB, van Kesteren RE
Early restoration of parvalbumin interneuron activity prevents memory loss and network hyperexcitability in a mouse model of Alzheimer's disease.
Mol Psychiatry. 2019 Aug 20; PubMed: 31431685PAPER Wolters AF, van de Weijer SC, Leentjens AF, Duits AA, Jacobs HI, Kuijf ML
"Resting-state fMRI in Parkinson's disease patients with cognitive impairment: A meta-analysis": Answer to Wang and colleagues.
Parkinsonism Relat Disord. 2019 Sep;66:253-254. Epub 2019 Jul 12 PubMed: 31431324PAPER Hirano K, Fujimaki M, Sasazawa Y, Yamaguchi A, Ishikawa KI, Miyamoto K, Souma S, Furuya N, Imamichi Y, Yamada D, Saya H, Akamatsu W, Saiki S, Hattori N
Neuroprotective effects of memantine via enhancement of autophagy.
Biochem Biophys Res Commun. 2019 Oct 8;518(1):161-170. Epub 2019 Aug 17 PubMed: 31431260PAPER Svobodova B, Mezeiova E, Hepnarova V, Hrabinova M, Muckova L, Kobrlova T, Jun D, Soukup O, Jimeno ML, Marco-Contelles J, Korabecny J
Exploring Structure-Activity Relationship in Tacrine-Squaramide Derivatives as Potent Cholinesterase Inhibitors.
Biomolecules. 2019 Aug 19;9(8) PubMed: 31430943PAPER Sycheva M, Sustarich J, Zhang Y, Selvaraju V, Geetha T, Gearing M, Babu JR
Pro-Nerve Growth Factor Induces Activation of RhoA Kinase and Neuronal Cell Death.
Brain Sci. 2019 Aug 19;9(8) PubMed: 31430874PAPER Kjeldsen PL, Damholdt MF
Subjective cognitive complaints in patients with Parkinson's disease.
Acta Neurol Scand. 2019 Dec;140(6):375-389. Epub 2019 Oct 9 PubMed: 31433855PAPER Fiorenzato E, Antonini A, Camparini V, Weis L, Semenza C, Biundo R
Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.
J Neural Transm (Vienna). 2019 Nov;126(11):1437-1445. Epub 2019 Aug 20 PubMed: 31432258PAPER Lee HJ, Lee SK, Lee DR, Choi BK, Le B, Yang SH
Ameliorating effect of Citrus aurantium extracts and nobiletin on β‑amyloid (1‑42)‑induced memory impairment in mice.
Mol Med Rep. 2019 Oct;20(4):3448-3455. Epub 2019 Aug 9 PubMed: 31432129PAPER Lee S, Na SH, Chung YA, Jeong H, Song IU
Efficacy of nicergoline treatment in Parkinson's disease associated with dementia.
J Clin Neurosci. 2019 Dec;70:136-139. Epub 2019 Aug 17 PubMed: 31431403PAPER Mestre TA, Guttman M
The dawn of a new era for neurodegenerative disorders: Huntington's disease leading the way.
Mov Disord. 2019 Sep;34(9):1301-1302. Epub 2019 Aug 21 PubMed: 31433876PAPER Sakae N, Josephs KA, Litvan I, Murray ME, Duara R, Uitti RJ, Wszolek ZK, Graff-Radford NR, Dickson DW
Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy.
Mov Disord. 2019 Nov;34(11):1655-1662. Epub 2019 Aug 21 PubMed: 31433871Current Filters
- Date Range : Aug 2019 to Nov 2019 x